ESMO 2017: Industry Sponsored Satellite Symposia

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Friday 8 September 2017

A New Era for Patients With ALK+ NSCLC: Transforming Clinical Practice

A New Era for Patients With ALK+ NSCLC: Transforming Clinical Practice - square

Friday, 18:00 - 19:30
View the satellite invitation

Are You Geared Up to Surf the Cancer Immunotherapy Waters?

Are You Geared Up To Surf The Cancer Immunotherapy Waters? - square

Friday, 18:00 - 19:30
View the satellite invitation

Biomarkers for Immuno-Oncology: PD-L1 and Beyond

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion square

Friday, 18:00 - 20:00
View the satellite invitation

Biosimilars for Oncologists: What you Need to Know 

Biosimilars for Oncologists: What you Need to Know - square

Friday, 18:00 - 20:00
View the satellite invitation

Breakthroughs in HCC: Extending Overall Survival Beyond Progression with Regorafenib

Breakthroughs in HCC: Extending Overall Survival Beyond Progression with Regorafenib - square

Friday, 18:00 - 20:00
View the satellite invitation

Inside the Mind of an RCC Treating Physician: Knowledge and Hypotheses of Today, Hope for the Future

Treating mRCC: Clinical Considerations in an Evolving Treatment Landscape square

Friday, 18:00 - 20:00
View the satellite invitation

Oncology Biosimilars on the Horizon: Key Points to Consider

Oncology Biosimilars on the Horizon: Key Points to Consider - square

Friday, 18:00 - 20:00
View the satellite invitation

Women Against Prostate Cancer: Optimal Use of Chemotherapy in Metastatic Prostate Cancer

Women Against Prostate Cancer: Optimal Use of Chemotherapy in Metastatic Prostate Cancer - square

Friday, 18:00 - 20:00
View the satellite invitation

Saturday 9 September 2017

aRCC-Essentials-in-Anti-VEGF-targeted-Therapy-for-Clinical-Application

aRCC: Essentials in Anti-VEGF-targeted Therapy for Clinical Application - square

Saturday, 13:00 - 14:30
View the satellite invitation

Clinical Considerations in Lung and Head & Neck Cancers: Where Are We Now and Where Are We Going?

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion square

Saturday, 13:00 - 14:30
View the satellite invitation

Evaluating Current and Emerging Strategies Using Checkpoint Inhibitors in the Fight Against Advanced/Metastatic Lung Cancer

Evaluating Current and Emerging Strategies Using Checkpoint Inhibitors in the Fight Against Advanced/Metastatic Lung Cancer - square

Saturday, 13:00 - 14:30
View the satellite invitation

Measuring Change in HR+/HER2– mBC - The Impact of CDK4/6 Inhibitors

Measuring Change in HR+/HER2–mBC -  The Impact of CDK4/6 Inhibitors - square

Saturday, 13:00 - 14:30
View the satellite invitation

Setting a New Standard of Care in Advanced Lung Cancer

The Future of Checkpoint Inhibition in Cancer square

Saturday, 13:00 - 14:30
View the satellite invitation

The Place of Targeted Alpha Therapy Optimising Overall Survival in mCRPC Today and in the Future

The Place of Targeted Alpha Therapy Optimizing Overall Survival in mCRPC Today and in the Future - square

Saturday, 13:00 - 14:30
View the satellite invitation

Therapeutic Options for the Patient Beyond 2nd Line in mCRC

Therapeutic Options for the Patient Beyond 2nd Line in mCRC - square

Saturday, 13:00 - 14:30
View the satellite invitation

Delineating the Differences Trastuzumab Biosimilar Development Reviewed

Delineating the Differences Trastuzumab Biosimilar Development Reviewed - square

Saturday, 18:00 - 20:00
View the satellite invitation

Breast Cancer Brain Metastases: An integrated approach

Breast Cancer Brain Metastases: An integrated approach - square

Saturday, 18:30 - 20:00
View the satellite invitation

The Evolving Treatment Landscape for Patients With ALK+ NSCLC

The Evolving Treatment Landscape for Patients With ALK+ NSCLC - square

Saturday, 18:30 - 20:00
View the satellite invitation

WWW - Who, What, Why: Optimising Treatment Selection in Real World, +HR Advanced Breast Cancer

WWW - Who, What, Why: Optimizing Treatment Selection in Real World, +HR Advanced Breast Cancer - square

Saturday, 18:30 - 20:00
View the satellite invitation

Sunday 10 September 2017

Expert Roundtable in Thoracic-Cancers: Finding Our Paradigms in an Evolving Landscape

Expert Roundtable in Thoracic-Cancers: Finding Our Paradigms in an Evolving Landscape - square

Sunday, 13:00 - 14:30
View the satellite invitation

Next Generation Sequencing - Driving Precision Oncology Research 

Next Generation Sequencing - Driving Precision Oncology Research - square

Sunday, 13:00 - 14:30
View the satellite invitation

The Future of Checkpoint Inhibition in Cancer Are We About to Challenge the Standard of Care Across Multiple Solid Tumors

The Future of Checkpoint Inhibition in Cancer square

Sunday, 13:00 - 14:30
View the satellite invitation

What Would You Do? Finding the Optimal Treatment for HER2 positive Early Breast Cancer

What Would You Do? Finding the Optimal Treatment for HER2 positive Early Breast Cancer - square

Sunday, 13:00 - 14:30
View the satellite invitation

Current and Emerging Immuno-Oncology Research in Gastrointestinal Cancers

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion square

Sunday, 18:30 - 20:00
View the satellite invitation

Integrating Multikinase Inhibitors Across GI Malignancies

Integrating Multikinase Inhibitors Across GI Malignancies - square

Sunday, 18:30 - 20:00
View the satellite invitation

The Role of PARP Inhibitors in Ovarian Cancer An Emerging Picture

The Role of PARP Inhibitors in Ovarian Cancer An Emerging Picture - square

Sunday, 18:30 - 20:00
View the satellite invitation

Strength in Numbers: Teaming Up for Better Patient Outcomes

Strength in Numbers: Teaming Up for Better Patient Outcomes - square

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 11 September 2017

Bringing Clarity to Immunotherapy in Lung Cancer: Translating Data into Clinical Decisions 

Bringing Clarity to Immunotherapy in Lung Cancer: Translating Data Into Clinical Decisions

Monday, 13:00 - 14:30
View the satellite invitation

Emerging Treatments for Patients With Cancer: Practical Guidance and Expert Insights

Emerging Treatments for Patients With Cancer: Practical Guidance and Expert Insights - square

Monday, 13:00 - 14:30
View the satellite invitation

Immuno-Oncology Research Across Melanoma Renal and Bladder Cancers: Where Are and Whats Next?

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion square

Monday, 13:00 - 14:30
View the satellite invitation

Navigating Advanced NSCLC: A Journey Through Daily Clinical Management

Navigating Advanced NSCLC: A Journey Through Daily Clinical Management - square

Monday, 13:00 - 14:30
View the satellite invitation

After the Clinical Trial: How Evidence from Clinical Practice is Transforming Patient Care

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion square

Sunday, 18:30 - 20:00
View the satellite invitation

Embarking on a New Era for Bladder Cancer Patients

The Future of Checkpoint Inhibition in Cancer square

Monday, 18:30 - 20:00
View the satellite invitation

Integrating New Treatments for HER2+ Early Breast Cancer

 Integrating New Treatments for HER2 Early Breast Cancer: Time for a Risk–Adapted Approach - square

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the Complete ESMO 2017 Industry Satellite Symposia Programme